Urogene

PharmaceuticalsSeries BParis, Franceurogene.com

Latest round

Series B

Last raised

Mar 2013

Total raised

$16M

Investors

3

About Urogene

Urogene, is based in Paris, France and is a biopharmaceutical company, develops drugs for urological diseases.

Who invested in Urogene

3 investors across 1 round

See all investors in Urogene

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Mar 19, 2013

    Amount

    $16M

    Investors

    Locked

Questions about Urogene

Who invested in Urogene?

Urogene has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Urogene raised?

Urogene has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Urogene last raise money?

Urogene's most recent round on record is a Series B, in Mar 2013.

What does Urogene do?

Urogene, is based in Paris, France and is a biopharmaceutical company, develops drugs for urological diseases.

Where is Urogene headquartered?

Urogene is headquartered in Paris, France.

Which VCs invest in companies like Urogene?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Urogene's stage. Their profiles are linked below.

Raising like Urogene? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.